Products

What will AGI do for Amiloride hydrochloride anhydrous?

This classification denotes the anhydrous form of a potassium-sparing diuretic and intercalating agent with the molecular formula C6H8ClN7O.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZJ37245UC, chemically known as pyrazinecarboxamide, n-amidino-3,5-diamino-6-chloro-, monohydrochloride but more generally known as amiloride hydrochloride, which bears US NIH Compound Identifier 16230. European Medicines Agency schedules Amiloride hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00445MIG. Most nations, for tariff and trade purposes, schedule amiloride hydrochloride anhydrous under HS 29339990. As of Q4 2014, AMILORIDE HYDROCHLORIDE ANHYDROUS remains US FDA's Preferred Term for this commodity. SMILES: C1(C(NC(C(N1)CL)N)N)C(=O)NC(=N)N.CL.

How AGI delivers it

Four ways AGI delivers for Amiloride hydrochloride anhydrous

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amiloride hydrochloride anhydrous, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amiloride hydrochloride anhydrous, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amiloride hydrochloride anhydrous connects

measured by

  • Active Ingredient Potencymodel
  • Chromatographic Assay Puritymodel
  • Crystal Form Puritymodel
  • Moisture Contentmodel